News
![Intra-Cellular Therapies](/sites/default/files/styles/x_large/public/2024-04/Intra-Cellular-Therapies-logo-960x540.jpg?itok=MXB-iClO)
Intra-Cellular sets up $500m offer on Caplyta depression win
Shares in Intra-Cellular Therapies rose sharply after it reported that its only product Caplyta was effective for a new indication, major depressive disorder (MDD), in a p